The constitutional mutations of MSH2 are the most frequently found in patients with endometrial cancer in the context of Lynch syndrome (40% of cases), followed by those of MLH1 and MSH6 (around 30% each). The gene discussed is MLH1; the disease is Lynch syndrome.